本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PTC Therapeutics Inc.

67.93
-0.3800-0.56%
盘后67.930.00000.00%18:33 EST
成交量:102.42万
成交额:6,902.79万
市值:53.96亿
市盈率:8.80
高:69.24
开:67.86
低:66.10
收:68.31
52周最高:69.88
52周最低:35.95
股本:7,943.81万
流通股本:6,501.02万
量比:1.33
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):7.72
每股收益(LYR):-4.7276
净资产收益率:-7740.12%
总资产收益率:23.81%
市净率:-26.13
市盈率(LYR):-14.37

数据加载中...

2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities